Literature DB >> 10531225

Lysine residue 117 of the FasG adhesin of enterotoxigenic Escherichia coli is essential for binding of 987P fimbriae to sulfatide.

B K Choi1, D M Schifferli.   

Abstract

The FasG subunit of the 987P fimbriae of enterotoxigenic strains of Escherichia coli was previously shown to mediate fimbrial binding to a glycoprotein and a sulfatide receptor on intestinal brush borders of piglets. Moreover, the 987P adhesin FasG is required for fimbrial expression, since fasG null mutants are nonfimbriated. In this study, fasG was modified by site-directed mutagenesis to study its sulfatide binding properties. Twenty single mutants were generated by replacing positively charged lysine (K) or arginine (R) residues with small, nonpolar alanine (A) residues. Reduced levels of binding to sulfatide-containing liposomes correlated with reduced fimbriation and FasG surface display in four fasG mutants (R27A, R286A, R226A, and R368). Among the 16 remaining normally fimbriated mutants with wild-type levels of surface-exposed FasG, only one mutant (K117A) did not interact at all with sulfatide-containing liposomes. Four mutants (K117A, R116A, K118A, and R200A) demonstrated reduced binding to such liposomes. Since complete phenotypic dissociation between the structure and specific function of 987P was observed only with mutant K117A, this residue is proposed to play an essential role in the FasG-sulfatide interaction, possibly communicating with the sulfate group of sulfatide by hydrogen bonding and/or salt bridge formation. Residues K17, R116, K118, and R200 may stabilize this interaction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10531225      PMCID: PMC96951     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

Review 1.  Protein binding versus protein folding: the role of hydrophilic bridges in protein associations.

Authors:  D Xu; S L Lin; R Nussinov
Journal:  J Mol Biol       Date:  1997-01-10       Impact factor: 5.469

2.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

3.  Protection against enteric disease caused by Escherichia coli--a model for vaccination with a virulence determinant?

Authors:  J M Rutter; G W Jones
Journal:  Nature       Date:  1973-04-20       Impact factor: 49.962

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  Immunoblotting and dot immunobinding--current status and outlook.

Authors:  H Towbin; J Gordon
Journal:  J Immunol Methods       Date:  1984-09-04       Impact factor: 2.303

6.  Role of the K88 antigen in the pathogenesis of neonatal diarrhea caused by Escherichia coli in piglets.

Authors:  G W Jones; J M Rutter
Journal:  Infect Immun       Date:  1972-12       Impact factor: 3.441

7.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

8.  Colonization of porcine intestine by enterotoxigenic Escherichia coli: selection of piliated forms in vivo, adhesion of piliated forms to epithelial cells in vitro, and incidence of a pilus antigen among porcine enteropathogenic E. coli.

Authors:  B Nagy; H W Moon; R E Isaacson
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

9.  In vitro adhesion of Escherichia coli to porcine small intestinal epithelial cells: pili as adhesive factors.

Authors:  R E Isaacson; P C Fusco; C C Brinton; H W Moon
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

10.  Role of Escherichia coli colonisation factor antigen in acute diarrhoea.

Authors:  T K Satterwhite; D G Evans; H L DuPont; D J Evans
Journal:  Lancet       Date:  1978-07-22       Impact factor: 79.321

View more
  9 in total

1.  Characterization of FasG segments required for 987P fimbria-mediated binding to piglet glycoprotein receptors.

Authors:  B K Choi; D M Schifferli
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

2.  Mapping the binding domain of the F18 fimbrial adhesin.

Authors:  A Smeds; M Pertovaara; T Timonen; T Pohjanvirta; S Pelkonen; A Palva
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 3.  Evolution of the chaperone/usher assembly pathway: fimbrial classification goes Greek.

Authors:  Sean-Paul Nuccio; Andreas J Bäumler
Journal:  Microbiol Mol Biol Rev       Date:  2007-12       Impact factor: 11.056

Review 4.  Animal Enterotoxigenic Escherichia coli.

Authors:  J Daniel Dubreuil; Richard E Isaacson; Dieter M Schifferli
Journal:  EcoSal Plus       Date:  2016-10

5.  Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.

Authors:  H Chen; D M Schifferli
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

6.  Passive antibodies derived from intramuscularly immunized toxoid fusion 3xSTaN12S-dmLT protect against STa+ enterotoxigenic Escherichia coli (ETEC) diarrhea in a pig model.

Authors:  Rahul M Nandre; Qiangde Duan; Yin Wang; Weiping Zhang
Journal:  Vaccine       Date:  2016-12-22       Impact factor: 3.641

7.  Enhanced immune responses to viral epitopes by combining macrophage-inducible expression with multimeric display on a Salmonella vector.

Authors:  H Chen; D M Schifferli
Journal:  Vaccine       Date:  2001-04-06       Impact factor: 3.641

8.  Genetic fusions of heat-labile (LT) and heat-stable (ST) toxoids of porcine enterotoxigenic Escherichia coli elicit neutralizing anti-LT and anti-STa antibodies.

Authors:  Weiping Zhang; Chengxian Zhang; David H Francis; Ying Fang; David Knudsen; James P Nataro; Donald C Robertson
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

9.  Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera Vaccines.

Authors:  Aqel Albutti; Stephanie Longet; Craig P McEntee; Shauna Quinn; Alex Liddicoat; Cristiana Rîmniceanu; Nils Lycke; Lydia Lynch; Susanna Cardell; Ed C Lavelle
Journal:  Vaccines (Basel)       Date:  2021-06-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.